The PTX3/TLR4 Autocrine Loop as a Novel Therapeutic Target in Triple Negative Breast Cancer

To understand the effects of pentraxin-3 (PTX3) in TNBC, different cell lines were engineered to knock-down or overexpress PTX3. The contribution of tumor and stromal cells to PTX3 production in TNBC was also assessed.